Novartis has a rich history of investing in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs. As the industry faces acute disruption, the company’s prescription for ongoing success hinges on APIs and microservices. Pascal Bouquet, Global Head of Architecture for Drug Development, answers a few questions about how digital transformation is moving Novartis forward.
Other content in this Stream
3:25Automated discovery and management of APIs with the Amplify API Management Platform.
800 IT and business leaders weigh in on how they’re managing the challenges of an increasingly complex API landscape
The speed and frequency of cyberattacks are rising and they can strike anywhere at any time in any digital ecosystem – even yours.
A quick take on securely managing and reusing APIs and events across multiple teams, clouds, and vendors.
As of Apple’s April 26th launch of iOS 14.5, apps must start using the company’s new App Tracking Transparency framework. As Brenton House recently explained, this change centers around access to...
In my previous Amplify Whiteoboard articles, I covered an open API Management Plane and API Discovery and Subscriptions. Today, we cover API observability and traffic analytics. API observability...
Enterprises that are well along their digital transformation journey are attaining new levels of maturity. But with that maturity comes increased complexity. Organizations are becoming...
Global energy equipment provider accelerates delivery of in-demand, value-added customer services
SUEZ embarks on its digital transformation journey with ultra-efficient, API-driven services
Why an open platform is a natural selection in a world of rapidly evolving security threats.